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a b s t r a c t
Neurally mediated reﬂex syncope is the most common cause of syncope in young individuals without
cardiac or neurological pathology. We report a case of successful catheter ablation in a 17-year-old male
with neurally mediated syncope (NMS) of the cardioinhibitory type. The patient had dextrocardia situs
inversus totalis with a mirror-image reversal of the thoracic and abdominal organs. Because he
experienced multiple syncope episodes despite pharmacological intervention, we performed endocar-
dial ablation of the superior vena cava–aorta ganglionated plexus. Shortly afterwards, his heart rate
increased from 40 to 76 beats per minutes. He has not experienced syncope during the 1-year follow-up.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Neurally mediated syncope (NMS) is the most common cause
of transient loss of consciousness, and is a clinical condition that
reduces the quality of life [1]. Cardioinhibition with asystole or a
transitory atrioventricular block induced by a massive vagal reﬂex
is commonly observed in severe cases [2,3]. No proven effective
pharmacological therapy exists for the prevention of NMS [4].
Dual-chamber permanent pacing is effective in reducing the
occurrence of syncope, but involves permanent device placement
[5]. Recently, Pachon et al. reported that endocardial catheter
ablation showed excellent long-term results in well-selected NMS
patients [6]. In the present case, we report the outcome of a
patient with severe NMS associated with signiﬁcant cardioinhibi-
tion who was treated by endocardial ablation with an approach
through the superior vena cava (SVC).
2. Case report
A 17-year-old male was referred to the emergency department
of our hospital for multiple episodes of syncope that were
refractory to pharmaceutical therapy. He had experienced some
syncopal episodes in childhood. Since 2011, he had been experi-
encing syncope accompanied by convulsions several times a week.
His physical examination and basic laboratory data were
normal. No organic heart disease other than dextrocardia was
detected on electrocardiography, chest radiography, and echo-
cardiography (Fig. 1).
The patient's 1231-metaiodobenzylguanidine cardiac uptake
was slightly decreased (heart-to-mediastinum count ratio¼1.81).
A head-up tilt test (HUT) was performed according to the ESC/
ACC guidelines [7,8]. Three minutes of tilting induced sinus arrest
with a 4-s duration. We therefore diagnosed the patient with the
cardioinhibitory type of NMS. Treatment with oral disopyramide
(200 mg) and metligine (4 mg) was initiated. One month later,
a repeat HUT demonstrated only severe hypotension (from
124/52 mmHg to 80/46 mmHg) with dizziness occurring 3 min
after the start of isoproterenol infusion (0.01 μg/kg/min) and an
increase in heart rate from 92 to 106 beats per minute. The patient
was educated about his medications, tilt-training, and a lifestyle
geared towards preventing syncope. However, similar episodes of
syncope continued to occur and another HUT conﬁrmed the
occurrence of an 8.5-s sinus arrest associated with syncope
13 min after tilting (Fig. 6). In accordance with current guidelines,
we recommended pacemaker implantation [9], which was refused
by the patient and his family. However, they did agree to endo-
cardial ablation and written consent was obtained.
The ablation procedure was performed under mild conscious
sedation. Skin adhesives of the CARTO 3 3D mapping system
(Biosense Webster, Diamond Bar, CA, USA) were applied (Fig. 2A).
A single circular mapping catheter (Lasso, Biosense Webster)
was placed in the SVC. The ablations were anatomically guided
using an irrigated catheter with a temperature-controlled system
(NaviStar ThermoCool, Biosense Webster). Endocardial ablation
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Fig. 1. Twelve-lead electrocardiography and chest radiography.
Fig. 2. Catheter ablation using a three-dimensional system. (A) The left panel shows the right lateral view and the right panel shows the cranial view. The three-dimensional
mapping system shows the superior vena cava (SVC), right atrium (RA), aorta (Ao), pulmonary vein (PV), vertebrae (Ve), and left ventricle (LV). The yellow and red points
indicate the sites of ablation. (B) and (C) Heart rates are increased at the yellow points (B1–4), at which potentials are recorded by the contact bipolar catheter. Heart rates are
not increased at the red points.
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was also performed through the SVC in the area between the aorta
and the SVC. Temperature-controlled radiofrequency energy lim-
ited to 25 W/50 1C was applied to a total of 10 points while
anatomical locations along with local potentials representing the
ﬁbrillar myocardium were identiﬁed using contact bipolar recording.
The heart rate quickly increased at 4 out of the 10 ablated points
(Fig. 2B and C). After ablation, the basic cycle length (BCL)
increased from 1475 ms to 791 ms and the heart rate ﬂuctuation
stabilized (Fig. 3). There were no procedure-related complications.
We assessed changes in heart rate variability by comparing pre-
ablation and post-ablation 24-h Holter electrocardiographic
recordings.
High frequency (HF, 0.15–0.4 Hz) power, representing respira-
tory sinus arrhythmia, is shown in Fig. 4. The ablation procedure
reduced HF (an example is shown in the left panel of Fig. 4), and
the low frequency (LF, 0.05–0.1 Hz)/HF ratio slightly increased.
Fig. 3. Pre- and post-ablation 12-lead electrocardiograms are shown. The basic cycle length increased from 1475 ms to 791 ms and the heart rate ﬂuctuation stabilized.
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Fig. 4. Comparison of pre- and post-ablation heart rate variability (HRV). HF, high frequency; LF, low frequency. HF range: 0.15–0.4 Hz; LF range: 0.05–0.1 Hz.
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Fig. 5. Comparison between the minimal, mean, and maximal heart rates on Holter
monitoring pre- and post-ablation.
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After ablation, there were minor increases in the minimal and
mean heart rates, but the maximal heart rate was not increased
(Fig. 5). A post-ablation HUT conducted during the 12-month
follow-up period was negative (Fig. 6), and the patient did not
experience any episodes of NMS.
3. Discussion
Ordinarily, a pacemaker should have been implanted in such a
case if the medical treatment option for syncope was insufﬁcient.
However, the patient and his family refused such treatment and
we empirically predicted that the mean heart rate would increase
after ablation of the cardiac ganglionic plexi (GP). Pachon et al.
reported on the treatment of NMS with endocardial catheter
ablation, which showed excellent long-term outcomes in well-
selected patients. In successfully treated patients, permanent
pacemaker implantation was not necessary [6]. They performed
spectral mapping-guided ablation in three anatomical areas:
between the aorta and SVC, between the right pulmonary veins
and the right atrium, and in the inferior–posterior interatrial
septum. In the present case, however, our endocardial ablation
target was determined anatomically only via direct visualization of
the SVC–aorta GP between the aorta and the SVC through the SVC.
Afterwards, we did not ablate other areas as the patient had
dextrocardia and the risks of complications such as trans-septal
puncture were higher. Indeed, heart rates after ablation through
the SVC obviously increased and the heart rate ﬂuctuation stabi-
lized, suggesting that ablation from a single approach was sufﬁ-
cient in this patient. We considered these responses to constitute
the endpoint of this procedure.
The cardiac GP are a collection of autonomic nervous systems
comprising both afferent and efferent as well as sympathetic and
parasympathetic ﬁbers [10,11]. Radiofrequency catheter ablation
eliminates the most elementary level of vagal innervation by
destroying the visceral efferent limb of the parasympathetic
system, thereby attenuating neural reﬂexes. In contrast to the
parasympathetic neuron, the post-ganglionic sympathetic neuron
is preserved, as its neural body is located far from the heart in the
paravertebral sympathetic chain and its axon usually recovers [6].
Several studies showed that a high number of parasympathetic
neurons and ganglia exist in the ﬁbrillar myocardium areas, which
are targeted by endocardial radiofrequency ablation aimed
at cardiac autonomic innervation [12]. Although we could not
ﬁnd obvious ﬁbrillar potentials, radiofrequency delivery caused
immediate autonomic reactions with an increase in heart rate.
Mapping guided by HF stimulation might have allowed a vagal
response to be elicited more efﬁciently from the GP embedded in
the epicardial fat pads.
After ablation, denervation was indicated by the signiﬁcant
HF reduction. Effective denervation was also supported by the
disappearance of vasovagal syncope episodes at least up to 12
months after the ablation.
4. Conclusion
We presented a case of NMS in which catheter ablation at the
SVC was safe and effective.
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